Related Experiment Video
Updated: Sep 13, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.0K
Tumor Microenvironment in Melanoma-Characteristic and Clinical Implications
Hubert Sikorski1, Michał Aleksander Żmijewski1, Anna Piotrowska1
1Department of Histology, Faculty of Medicine, Medical University of Gdańsk, Dębinki 1 Str., 80-211 Gdańsk, Poland.
International Journal of Molecular Sciences
|July 29, 2025
Summary
The tumor microenvironment (TME) is crucial for melanoma progression. Understanding its cellular components, like cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs), is key for developing new melanoma treatments.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Cutaneous melanoma incidence is rising globally, necessitating research into its pathogenesis.
- The tumor microenvironment (TME) significantly influences melanoma progression, comprising cellular elements and an extracellular matrix (ECM).
Purpose of the Study:
- To explore the multifaceted roles of various cellular components within the melanoma tumor microenvironment.
- To highlight the impact of the TME on melanoma progression and immune evasion.
Main Methods:
- Review of current literature on melanoma pathogenesis and TME composition.
- Analysis of the functions of key cellular players including cancer-associated fibroblasts (CAFs), tumor-associated macrophages (TAMs), tumor-infiltrating lymphocytes (TILs), and dendritic cells (DCs).
Main Results:
- Cancer-associated fibroblasts (CAFs) remodel the ECM and modulate immune responses.
- Tumor-associated macrophages (TAMs) polarized to M2 phenotype promote tumor progression.
- Tumor-infiltrating lymphocytes (TILs) and dendritic cells (DCs) exhibit diverse, complex roles, including immune suppression and evasion.
Conclusions:
- The cellular components of the TME are critical drivers of melanoma tumorigenesis.
- Emerging therapeutic strategies targeting the TME, gut microbiome, and personalized approaches like neoantigen vaccines show promise for future melanoma treatment.
Keywords:
cancer/melanoma-associated fibroblasts (CAFs)dendritic cellsimmune checkpoint inhibitors (ICI)macrophagesmelanomametastasestumor microenvironmenttumor-infiltrating lymphocytes (TILs)More Related Videos
Related Concept Videos
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Skin Cancer
4.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.6K
Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662

